| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_93f42eaa3ae7b0f778e0e922c293999f |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2318-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2318-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-56 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2863
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-22 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K19-00 |
| filingDate |
2006-11-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c24f24f0480cc3cae84acb79c7f05a66
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5212dd65ba86a0d2292503f23316e195
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8a3de3a877295a0afcf70280d599635a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4e774c6e50d322945cfb64c2db386dc1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ce042bfbce4cc9facc2690cbe19eb1e0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_253788b97b985275f449951b74324304
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_47d85abf916a5cd237676f67b53ba15b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4aee0be0ab273f214d18ce253ab87817
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e70fad8f78f4d38207e68074238e806e |
| publicationDate |
2008-08-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-1957541-A2 |
| titleOfInvention |
Compositions and methods of producing hybrid antigen binding molecules and uses thereof |
| abstract |
This disclosure relates to hybrid antigen binding molecules including at least two polypeptide chains, with at least one polypeptide chain comprises an antigen binding moiety linked to an amino acid sequence of a subunit of a heterodimeric proteinaceous hormone. Also disclosed are methods of making and using such hybrid antigen binding molecules for diagnosis and/or therapy. |
| priorityDate |
2005-11-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |